Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial von CHENG, Ann-Lii, KANG, Yoon-Koo, OMATA, Masao, LOWENTHAL, Susan Pitman, LANZALONE, Silvana, LIQIANG YANG, JOSE LECHUGA, Maria, RAYMOND, Eric, LIN, Deng-Yn, PARK, Joong-Won, KUDO, Masatoshi, SHUKUI QIN, CHUNG, Hyun-Cheol, XIANGQUN SONG, JIANMINGXU, POGGI, Guido

Volltext

Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study von LLOVET, Josep M, DECAENS, Thomas, MATHURIN, Philippe, FARTOUX, Laetitia, LIN, Deng-Yn, BRUIX, Jordi, POON, Ronnie T, SHERMAN, Morris, BLANC, Jean-Frédéric, FINN, Richard S, TAK, Won-Young, YEE CHAO, RAOUL, Jean-Luc, EZZEDDINE, Rana, LIU, David, WALTERS, Ian, PARK, Joong-Won, BOUCHER, Eveline, KUDO, Masatoshi, CHANG, Charissa, KANG, Yoon-Koo, ASSENAT, Eric, LIM, Ho-Yeong, BOIGE, Valerie

Volltext

Long‐term outcome of hepatitis B e antigen–negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time von Tai, Dar‐In, Lin, Shi‐Ming, Sheen, I‐Shyan, Chu, Chia‐Ming, Lin, Deng‐Yn, Liaw, Yun‐Fan

Volltext

Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection von CHEN, Li-Tzong, CHEN, Miin-Fu, CHAU, Gar-Yang, CHEN, Yaw-Sen, LUI, Wing-Yui, HSIAO, Chin-Fu, WHANG-PENG, Jacqueline, CHEN, Pei-Jer, LI, Lung-An, LEE, Po-Huang, JENG, Long-Bin, LIN, Deng-Yn, WU, Cheng-Chung, KING-TONG MOK, CHEN, Chao-Long, LEE, Wei-Chen

Volltext

Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence von Liu, Chun-Jen, Chang, Juliana, Lee, Po-Huang, Lin, Deng-Yn, Wu, Cheng-Chung, Jeng, Long-Bin, Lin, Yih-Jyh, Mok, King-Tong, Lee, Wei-Chen, Yeh, Hong-Zen, Ho, Ming-Chih, Yang, Sheng-Shun, Yang, Mei-Due, Yu, Ming-Chin, Hu, Rey-Heng, Peng, Cheng-Yuan, Lai, Kuan-Lang, Chang, Stanley Shi-Chung, Chen, Pei-Jer

Volltext

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage von Liu, Chun-Jen, Lee, Po-Huang, Lin, Deng-Yn, Wu, Cheng-Chung, Jeng, Long-Bin, Lin, Pin-Wen, Mok, King-Tong, Lee, Wei-Chen, Yeh, Hong-Zen, Ho, Ming-Chih, Yang, Sheng-Shun, Lee, Ching-Chih, Yu, Ming-Chin, Hu, Rey-Heng, Peng, Cheng-Yuan, Lai, Kuan-Lang, Chang, Stanley Shi-Chung, Chen, Pei-Jer

Volltext

Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese: Analysis of 34 669 cases von Lin, Wey-Ran, Lin, Deng-Yn, Tai, Dar-In, Hsieh, Sen-Yung, Lin, Chun-Yen, Sheen, I-Shyan, Chiu, Cheng-Tang

Volltext

Prospective randomized controlled study of interferon‐alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors von Lin, Shi‐Ming, Lin, Chun‐Jung, Hsu, Chao‐Wei, Tai, Dar‐In, Sheen, I‐Shyan, Lin, Deng‐Yn, Liaw, Yun‐Fan

Volltext

Clinical and Virological Characteristics Post HBsAg Seroclearance in Hepatitis B Virus Carriers With Hepatic Steatosis Versus Those Without von Chu, Chia-Ming, Lin, Deng-Yn, Liaw, Yun-Fan

Volltext

Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection von Lee, Chuan‐Mo, Lu, Sheng‐Nan, Changchien, Chi‐Sin, Yeh, Chau‐Ting, Hsu, Tsung‐Teng, Tang, Jui‐Hsiang, Wang, Jing‐Houng, Lin, Deng‐Yn, Chen, Chao‐Long, Chen, Wei‐Jen

Volltext

Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis von Chang, Ming-Ling, Yeh, Chau-Ting, Chen, Jeng-Chang, Huang, Chau-Chun, Lin, Shi-Ming, Sheen, I-Shyan, Tai, Dar-In, Chu, Chia-Ming, Lin, Wei-Pin, Chang, Ming-Yu, Liang, Chun-Kai, Chiu, Cheng-Tang, Lin, Deng-Yn

Volltext

Aberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis von Shih, Tsung-Chieh, Hsieh, Sen-Yung, Hsieh, Yi-Yueh, Chen, Tse-Chin, Yeh, Chien-Yu, Lin, Chun-Jung, Lin, Deng-Yn, Chiu, Cheng-Tang

Volltext

Non-surgical treatment of hepatocellular carcinoma von LIN, DENG-YN, LIN, SHI-MING, LIAW, YUN-FAN

Volltext

Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activation von Chang, Ming-Ling, Yeh, Chau-Ting, Lin, Deng-Yn, Ho, Yu-Pin, Hsu, Chen-Ming, Bissell, D Montgomery

Volltext

Disproportional exaggerated aspartate transaminase is a useful prognostic parameter in late leptospirosis von Chang, Ming-Ling, Yang, Chih-Wei, Chen, Jeng-Chang, Ho, Yu-Pin, Pan, Ming-Jeng, Lin, Cheng-Hui, Lin, Deng-Yn

Volltext

High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities von HUANG, BING-SHEN, TSANG, NGAN-MING, LIN, SHI-MING, LIN, DENG-YN, LIEN, JAU-MIN, LIN, CHEN-CHUN, CHEN, WEI-TING, CHEN, WAN-YU, HONG, JI-HONG

Volltext

A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma von Yen, Chia-Jui, Kim, Tae-You, Feng, Yin-Hsun, Chao, Yee, Lin, Deng-Yn, Ryoo, Baek-Yeol, Huang, Dennis Chin-Lun, Schnell, David, Hocke, Julia, Loembé, Arsène-Bienvenu, Cheng, Ann-Lii

Volltext

Viral Load, Genotypes, and Mutants in Hepatitis B Virus-Related Hepatocellular Carcinoma: Special Emphasis on Patients with Early Hepatocellular Carcinoma von Chu, Chia-Ming, Lin, Chen-Chun, Lin, Shi-Ming, Lin, Deng-Yn, Liaw, Yun-Fan

Volltext

Hepatitis C virus infection facilitates gallstone formation von CHANG, TE-SHENG, LO, SING KAI, SHYR, HUEIH-YUAN, FANG, JI-TSENG, LEE, WEI-CHEN, TAI, DAR-IN, SHEEN, I-SHYAN, LIN, DENG-YN, CHU, CHIA-MING, LIAW, YUN-FAN

Volltext

Instantaneous Frequency-Based Ultrasonic Temperature Estimation During Focused Ultrasound Thermal Therapy von Liu, Hao-Li, Li, Meng-Lin, Shih, Tzu-Ching, Huang, Sheng-Min, Lu, I-Yeh, Lin, Deng-Yn, Lin, Shi-Ming, Ju, Kuen-Cheng

Volltext